SUSANA CARTER: Open Payments
NPI 1184365116 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$551 in 20 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $20 · 2025 $551
Food & beverage: $551
| Company | Payments | Amount |
|---|---|---|
| BETA BIONICS, INC. | 3 | $119 |
| Medtronic, Inc. | 1 | $67 |
| Merck Sharp & Dohme LLC | 3 | $56 |
| Ascendis Pharma Endocrinology Inc | 1 | $50 |
| Tandem Diabetes Care, Inc. | 1 | $40 |
| Paratek Pharmaceuticals, Inc. | 2 | $37 |
| Mallinckrodt Hospital Products Inc. | 1 | $27 |
| Novo Nordisk Inc | 1 | $26 |
| Dexcom, Inc. | 1 | $24 |
| Baxter Healthcare | 1 | $24 |
Products named: iLet Bionic Pancreas, MINIMED 780G, ZERBAXA, Yorvipath, t:slim X2 Insulin Pump with Control-IQ, NUZYRA, ACTHAR, Ozempic.
Industry payments across TX — which companies pay providers there.
